Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Microbicides development programme: engaging the community in the standard of care debate in a vaginal microbicide trial in Mwanza, Tanzania.

Vallely A, Shagi C, Lees S, Shapiro K, Masanja J, Nikolau L, Kazimoto J, Soteli S, Moffat C, Changalucha J, McCormack S, Hayes RJ.

BMC Med Ethics. 2009 Oct 9;10:17. doi: 10.1186/1472-6939-10-17.

2.

A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa.

Shagi C, Vallely A, Kasindi S, Chiduo B, Desmond N, Soteli S, Kavit N, Vallely L, Lees S, Hayes R, Ross D; Microbicides Development Programme.

AIDS Care. 2008 Oct;20(9):1039-49. doi: 10.1080/09540120701842803.

PMID:
18825513
3.

The benefits of participatory methodologies to develop effective community dialogue in the context of a microbicide trial feasibility study in Mwanza, Tanzania.

Vallely A, Shagi C, Kasindi S, Desmond N, Lees S, Chiduo B, Hayes R, Allen C, Ross D; Microbicides Development Programme.

BMC Public Health. 2007 Jul 2;7:133.

4.

How informed is consent in vulnerable populations? Experience using a continuous consent process during the MDP301 vaginal microbicide trial in Mwanza, Tanzania.

Vallely A, Lees S, Shagi C, Kasindi S, Soteli S, Kavit N, Vallely L, McCormack S, Pool R, Hayes RJ; Microbicides Development Programme (MDP).

BMC Med Ethics. 2010 Jun 13;11:10. doi: 10.1186/1472-6939-11-10.

5.

Are women who work in bars, guesthouses and similar facilities a suitable study population for vaginal microbicide trials in Africa?

Vallely A, Hambleton IR, Kasindi S, Knight L, Francis SC, Chirwa T, Everett D, Shagi C, Cook C, Barberousse C, Watson-Jones D, Changalucha J, Ross D, Hayes RJ; Microbicides Development Programme.

PLoS One. 2010 May 14;5(5):e10661. doi: 10.1371/journal.pone.0010661.

6.

Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.

Lanham M, Wilcher R, Montgomery ET, Pool R, Schuler S, Lenzi R, Friedland B.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19159. doi: 10.7448/IAS.17.3.19159. eCollection 2014.

7.

Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.

Doggett EG, Lanham M, Wilcher R, Gafos M, Karim QA, Heise L.

J Int AIDS Soc. 2015 Dec 21;18:20536. doi: 10.7448/IAS.18.1.20536. eCollection 2015. Review.

8.

Intravaginal and menstrual practices among women working in food and recreational facilities in Mwanza, Tanzania: implications for microbicide trials.

Allen CF, Desmond N, Chiduo B, Medard L, Lees SS, Vallely A, Francis SC, Ross DA, Hayes RJ.

AIDS Behav. 2010 Oct;14(5):1169-81. doi: 10.1007/s10461-010-9750-8.

10.

Community and research staff collaboration for development of materials to inform microbicide study participants in Africa.

Woodsong C, Mutsambi JM, Ntshele S, Modikoe P.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19156. doi: 10.7448/IAS.17.3.19156. eCollection 2014.

11.

Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.

Obiero J, Mwethera PG, Hussey GD, Wiysonge CS.

BMC Infect Dis. 2012 Nov 6;12:289. doi: 10.1186/1471-2334-12-289. Review.

12.

Community perspectives on care options for HIV prevention trial participants.

MacQueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A, Sahay S; HPTN 035 Standard of Care Assessment Team.

AIDS Care. 2007 Apr;19(4):554-60.

PMID:
17453597
13.

Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.

Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.

BMC Res Notes. 2012 Nov 1;5:613. doi: 10.1186/1756-0500-5-613.

14.

Topical microbicides for prevention of sexually transmitted infections.

Obiero J, Mwethera PG, Wiysonge CS.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD007961. doi: 10.1002/14651858.CD007961.pub2. Review.

PMID:
22696373
15.

The role of partnership dynamics in determining the acceptability of condoms and microbicides.

Montgomery CM, Lees S, Stadler J, Morar NS, Ssali A, Mwanza B, Mntambo M, Phillip J, Watts C, Pool R.

AIDS Care. 2008 Jul;20(6):733-40. doi: 10.1080/09540120701693974.

PMID:
18576176
16.

How effective is effective enough? Opinions of potential end-users of microbicides from a rural South African community.

Gafos M, Mzimela MA, Ndlovu HB, McCormack S, McGrath N.

AIDS Care. 2013;25(5):573-8. doi: 10.1080/09540121.2012.722604. Epub 2012 Sep 13.

17.

Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.

Nel A, Martins J, Bekker LG, Ramjee G, Masenga G, Rees H, van Niekerk N.

PLoS One. 2018 May 29;13(5):e0196904. doi: 10.1371/journal.pone.0196904. eCollection 2018.

18.

Twice-daily application of HIV microbicides alter the vaginal microbiota.

Ravel J, Gajer P, Fu L, Mauck CK, Koenig SS, Sakamoto J, Motsinger-Reif AA, Doncel GF, Zeichner SL.

MBio. 2012 Dec 18;3(6). pii: e00370-12. doi: 10.1128/mBio.00370-12.

19.

Standard of care for HIV prevention technology research: a consensus document from Nigeria.

Folayan MO, Falobi O, Faleyimu B, Ogunlayi M.

Afr J Med Med Sci. 2011 Sep;40(3):265-71.

PMID:
22428522
20.

To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.

Kelly CA, Friedland BA, Morar NS, Katzen LL, Ramjee G, Mokgatle MM, Ahmed K.

Cult Health Sex. 2015;17(8):1004-20. doi: 10.1080/13691058.2015.1030451. Epub 2015 Apr 27.

PMID:
25913101

Supplemental Content

Support Center